Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity—Nutraceutical Options

In people with metabolic syndrome, episodic exposure of pancreatic beta cells to elevated levels of both glucose and free fatty acids (FFAs)—or glucolipotoxicity—can induce a loss of glucose-stimulated insulin secretion (GSIS). This in turn can lead to a chronic state of glucolipotoxicity and a sust...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarty, Mark F., DiNicolantonio, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775473/
https://www.ncbi.nlm.nih.gov/pubmed/35052168
http://dx.doi.org/10.3390/healthcare10010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775473/
https://www.ncbi.nlm.nih.gov/pubmed/35052168
http://dx.doi.org/10.3390/healthcare10010003

Ejemplares similares